Becton Dickinson BDX is scheduled to report fiscal first-quarter earnings on February 8 before the market open, Morgan Keegan reports.
“We believe that BD shares [are] already reflecting a positive bias towards the first-quarter earnings and 2011 results given its premium valuation in the group,” Morgan Keegan writes. “We expect in-line top-line results with some modest EPS upside.
“We maintain our Market Perform rating on BD shares. We continue to view BD as well managed with a global footprint, new product flow, and opportunities to further reduce expenses. said, the current valuation is at a premium to other hospital-supply companies factors into our neutral investment rating at the current time.”
Becton Dickinson closed Wednesday at $83.64.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in